Cell density-dependent inhibition of growth and neural differentiation in the human neuroblastoma cell line SK-N-MC are associated with a ganglioside sialidasemediated increase of GM 1 and lactosylceramide at the cell surface. Because these glycolipids expose galactose residues, we have initiated the study of the potential role of galectins in such cellular events. Using specific antibodies, galectin-1 but not galectin-3 was found to be present at the cell surface. Assessment of carbohydratedependent binding revealed a saturable amount of ligand sites approaching 2.6 ؋ 10 6 galectin-1 molecules bound/cell. Presence during cell culture of the sialidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acid or of the GM 1 -binding cholera toxin B subunit effected a decrease of the presentation of galectin-1 ligands by 30 -50%. The assumption that GM 1 is a major ligand for galectin-1 was reinforced by the correlation between the number of carbohydrate-dependent 125 I-iodinated GM 1 -neoganglioprotein binding sites and the amount of immunoreactive surface galectin-1, the marked sensitivity of probe binding to the presence of anti-galectin-1 antibody, and the inhibition of cell adhesion to surfaceimmobilized GM 1 by the antibody. The results open the possibility that the carbohydrate-dependent interaction between ganglioside GM 1 and galectin-1 may relay sialidase-dependent alterations in this cell system.Gangliosides can exert a variety of cellular functions that include the triggering and modulation of transmembrane signaling and the mediation of recognition of receptor molecules in homotypic and heterotypic associations (1-4). Owing to this versatility in regulatory processes, it is fitting that the presentation of gangliosides at the cell surface is subject to control mechanisms that involve biosynthesis, endocytic uptake, recirculation, and lysosomal degradation (5, 6). Moreover, the structure of the oligosaccharide chains of gangliosides can be remodeled in situ by the action of a cell surface sialidase in the course of transformation, differentiation and cell contact formation (7-12). In human neuroblastoma cells (SK-N-MC), the activity of this sialidase was directed toward gangliosides with terminal sialic acids, yielding a shift from higher sialylated species to GM 1 and a conversion of GM 3 to lactosylceramide (13). Such alterations of the ganglioside profile are apparently of profound impact on the behavior of the neuroblastoma cells, because the selective inhibition of the ganglioside sialidase activity by 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (NeuAc2en) 1 led to marked changes in cellular morphology, a complete release from contact inhibition of growth, and a loss of differentiation markers (14,15). Because the underlying molecular events are unknown, we have now addressed questions on the presence and nature of potential receptors for GM 1 and/or lactosylceramide that are generated by the action of the ganglioside sialidase on the surface of neuroblastoma cells.The current literature prompts inves...